<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="7342">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00934622</url>
  </required_header>
  <id_info>
    <org_study_id>ALCONsur002.07</org_study_id>
    <nct_id>NCT00934622</nct_id>
  </id_info>
  <brief_title>Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric IOL</brief_title>
  <official_title>Visual Function After Implantation of Bilateral AcrySoft ReSTOR Aspheric Intraocular Lens (IOL)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <authority>Canada: Ethics Review Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will involve up to 20 bilateral patients per surgeon. Patients will be assessed
      pre-operatively, and at subsequent visits (following the implantation of the intraocular
      lens in the second eye) at 1 week, 1 month, 3 months and 6 months post-operatively.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>pre-operative;1 week,1 month, 3 months and 6 months after 2nd eye surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Comparison of visual acuity (measured in logMAR) prior to and following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL). Visual parameters were assessed prior to and after the implantation of the second lens at 1 week, 1 month, 3 months, and 6 months. LogMAR, the unit of measure for visual acuity, is the &quot;logarithm of the minimum angle of resolution&quot;. A lower logMAR value indicates better visual acuity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Spectacle Independence</measure>
    <time_frame>pre-op;1 week,1 month,3 months and 6 months after 2nd eye surgery</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Spectacle independence is the percentage of patients that do not always need to wear glasses. This outcome measure is patient reported.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">76</enrollment>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>AcrySof® ReSTOR® Aspheric IOL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AcrySof® ReSTOR® Aspheric IOL</intervention_name>
    <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL) implanted into the study eye following the cataract extraction surgery</description>
    <arm_group_label>AcrySof® ReSTOR® Aspheric IOL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  21 years or older;

          -  need spherical correction between 10-30 Diopters (D);

          -  corneal astigmatism less than 0.75D as measured by keratometry;

          -  willing to sign an Informed Consent Form and complete all visits;

          -  pupil dilation greater than 6mm;

          -  expected Visual Acuity (measured in logMAR)=0.3 or better

        Exclusion Criteria:

          -  Women of childbearing potential;

          -  irregular corneal astigmatism;

          -  keratopathy/keratectasia;

          -  cornea inflammation or edema;

          -  cornea reshaping surgery;

          -  corneal dystrophy;corneal transplant;

          -  amblyopia;

          -  glaucoma;

          -  Retinal Pigment Epitheliopathy (RPE)/Macular changes;

          -  proliferative diabetic retinopathy
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Alcon Call Center for Trial Locations</name>
      <address>
        <city>Fort Worth</city>
        <state>Texas</state>
        <zip>76134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <lastchanged_date>May 5, 2010</lastchanged_date>
  <firstreceived_date>July 7, 2009</firstreceived_date>
  <firstreceived_results_date>March 25, 2010</firstreceived_results_date>
  <responsible_party>
    <name_title>Doug Hubatsch\Clinical Research Director</name_title>
    <organization>Alcon Research</organization>
  </responsible_party>
  <keyword>AcrySof</keyword>
  <keyword>ReSTOR</keyword>
  <keyword>Aspheric IOL</keyword>
  <keyword>Cataract</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects &gt;21 years of age, either sex, and any race. Diagnosis of cataracts in both eyes. 27-Jun-2007 to 20-May-2009</recruitment_details>
      <pre_assignment_details>Subject’s eligibility was determined at the preoperative visit. All subjects met inclusion/exclusion criteria.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>AcrySof® ReSTOR® Aspheric IOL</title>
          <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="68"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>2nd Intraoperative exclusion criteria</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>AcrySof® ReSTOR® Aspheric IOL</title>
          <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="76"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>&lt;=18 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="0"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Between 18 and 65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="33"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>&gt;=65 years</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="43"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <description>Gender data not collected for 1 patient.</description>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="48"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="27"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Visual Acuity</title>
        <description>Comparison of visual acuity (measured in logMAR) prior to and following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL). Visual parameters were assessed prior to and after the implantation of the second lens at 1 week, 1 month, 3 months, and 6 months. LogMAR, the unit of measure for visual acuity, is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
        <time_frame>pre-operative;1 week,1 month, 3 months and 6 months after 2nd eye surgery</time_frame>
        <safety_issue>Yes</safety_issue>
        <group_list>
          <group group_id="O1">
            <title>AcrySof® ReSTOR® Aspheric IOL</title>
            <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="76"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Visual Acuity</title>
            <description>Comparison of visual acuity (measured in logMAR) prior to and following bilateral implantation of the AcrySof ReSTOR Aspheric Intraocular Lens (IOL). Visual parameters were assessed prior to and after the implantation of the second lens at 1 week, 1 month, 3 months, and 6 months. LogMAR, the unit of measure for visual acuity, is the “logarithm of the minimum angle of resolution”. A lower logMAR value indicates better visual acuity.</description>
            <units>logMAR</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>Preoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.54" spread="0.3"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 Week</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.06" spread="0.12"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 Month</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.03" spread="0.08"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>3 Months</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.04" spread="0.08"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 Months</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.05" spread="0.09"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Spectacle Independence</title>
        <description>Spectacle independence is the percentage of patients that do not always need to wear glasses. This outcome measure is patient reported.</description>
        <time_frame>pre-op;1 week,1 month,3 months and 6 months after 2nd eye surgery</time_frame>
        <safety_issue>Yes</safety_issue>
        <population>Patient population was not consistent throughout the study. Number of patients analyzed at each visit is as follows: Preoperative n=76, Week 1 n=61, 1 Month n=71, 3 Months n=70, 6 Months n=68.</population>
        <group_list>
          <group group_id="O1">
            <title>AcrySof® ReSTOR® Aspheric IOL</title>
            <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="76"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Spectacle Independence</title>
            <description>Spectacle independence is the percentage of patients that do not always need to wear glasses. This outcome measure is patient reported.</description>
            <units>Percentage of Participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <sub_title>Preoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 Week Postoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="96.8"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>1 Month Postoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="97.2"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>3 Months Postoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="98.6"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>6 Months Postoperative</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="100"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>June 27, 2007 (First Subject, first visit) through August 1, 2009 (Last subject, last visit)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>AcrySof® ReSTOR® Aspheric IOL</title>
          <description>AcrySof® ReSTOR® Aspheric Intraocular Lens (IOL)</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="76"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is less than or equal to 60 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Alcon Clinical</name_or_title>
      <organization>Alcon Research, Ltd.</organization>
      <phone>888.451.3937; 817.568.6725</phone>
      <email>medinfo@alconlabs.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
